Film coating

Details Film coating Film coating

2004-09-16

2010-10-19

Wax, Robert A (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

C424S458000, C424S474000, C424S490000

Reexamination Certificate

active

07815938

ABSTRACT:
A film coating composition suitable for use in coating pharmaceutical formulations to provide modified release comprising a dispersion which includes: a) an acrylic polymer, b) a vinyl acetate polymer, and c) a water-containing liquid. The film coat is useful for the achievement of modified release from pharmaceutical formulations such as tablets, pellets, etc.

REFERENCES:
patent: 3341338 (1967-09-01), Pater
patent: 3371015 (1968-02-01), Sjogren et al.
patent: 3775537 (1973-11-01), Lehmann et al.
patent: 4330338 (1982-05-01), Banker
patent: 4800087 (1989-01-01), Mehta
patent: 4871546 (1989-10-01), Feltz et al.
patent: 4916171 (1990-04-01), Brown et al.
patent: 4927640 (1990-05-01), Dahlinder et al.
patent: 4957745 (1990-09-01), Jonsson et al.
patent: 4975283 (1990-12-01), Patell
patent: 5246714 (1993-09-01), Dahlinder et al.
patent: 5292522 (1994-03-01), Petereit et al.
patent: 5478573 (1995-12-01), Eichel et al.
patent: 5594013 (1997-01-01), Trigger
patent: 5681584 (1997-10-01), Savastano et al.
patent: 5871776 (1999-02-01), Mehta
patent: 6008249 (1999-12-01), Gajdos et al.
patent: 6046177 (2000-04-01), Stella et al.
patent: 6627223 (2003-09-01), Percel et al.
patent: 6827947 (2004-12-01), Lofroth et al.
patent: 2004/0058001 (2004-03-01), Hölzer et al.
patent: 2005/0238719 (2005-10-01), Buzsaky
patent: 2005/0256255 (2005-11-01), Karlsson et al.
patent: 0 173 928 (1986-03-01), None
patent: 0 313 845 (1989-05-01), None
patent: 0 431 877 (1991-06-01), None
patent: 0 621 032 (1994-10-01), None
patent: 0 878 234 (1961-09-01), None
patent: WO 02/58677 (2002-08-01), None
Thermal Properties of Polymers: Polymer Glass Transition, http://plc.cwru.edu/tutorial/enhanced/files/polymers/therm/therm.htm, Nov. 6 , 2009.
J.C. Gutiérrez-Rocca et al., “Influence of water soluble and insoluble plasticizers on the physical and mechanical properties of acrylic resin copolymers”, International Journal of Pharmaceutics, 103 (1994) 293-303.
F. Lecomte et al., “Polymer blends used for the coating of multiparticulates: comparison of aqueous and organic coating techniques”, Pharmaceutical Research, Val. 21, No. 5, May 2004.
Röhm Pharma Polymers: Eudragit® sustained-release formulations for oral dosage forms/Eudragit acrylic polymers for controlled release/The complete range/Basic Info 2, pp. 1-20, Oct. 1995.
Röhm Pharma Polymers: 1. Eudragit® acrylic polymers—International availability and acceptance for use in the manufacture of pharmaceutical dosage forms (May 1996), pp. 1-10.
Röhm Pharma Polymers: Specifications and test methods for Eudragit® NE 30 D (Standards Sheet) (Jan. 1996), pp. 1-4.
Röhm Pharma Polymers: Specifications and test methods for Eudragit® NE 30 D-55 (Standards Sheet) (Jan. 1996), pp. 1-4.
BASF Fine Chemicals: Kollicoat® SR 30 D (Technical Information); Polyvinyl acetate dispersion for sustained-release pharmaceutical formulations (Jun. 1999), pp. 1-14.
BASF Fine Chemicals: Specifications of Kollicoat® SR 30 D (Data Sheet) (Sep. 2003), pp. 1-2.
BASF AG: Fine Chemicals: Pharma Solutions: Excipients: Kollicoat® SR 30 D (2002).
BASF Health and Nutrition: Kollicoat® EMM 30 D (Technical Information); Ethyl acrylate-methyl methacrylate copolymer for sustained-release pharmaceutical formulations (Aug. 1999), pp. 1-11.
BASF Fine Chemicals: Specifications of Kollicoat® EMM 30 D (Data Sheet) (Jul. 2003), pp. 1-2.
BASF AG: Fine Chemicals: Pharma Solutions: Excipients: Kollicoat® EMM 30 D (2002).
Kolter, K. et al., “Kollicoat® SR 30 D—Coatings on Different Drugs”, Proceed. Int'l. Symp. Control. Rel. Bioact. Mater., 27 (2000) Controlled Release Society, Inc., pp. 425-426.
Sandberg, A. et al., “Design of a New Multiple-Unit Controlled-Release Formulation of Metoprolol—Metoprolol CR”, European Journal of Clinical Pharmacology (1988)33 [Suppl] S3-S7.
Ragnarsson, G. et al., “Development of a New Controlled Release Metoprolol Product”, Drug Development and Industrial Pharmacy, 13(9-11), 1495-1509 (1987).
Hölzer A.W., “Friction and lubrication in tableting”, Industrial Aspects of Pharmaceuticals, Stockholm, Sandell, 1993 ISBN 91-86274465, pp. 153-172.
Z.M. Mathir et al., “In vitro characterization of a controlled-release chlorpheniramine maleate delivery system prepared by the air suspension technique”,J. Microencapsulation, 1977, vol. 14, No. 6, 743-751.
H-U Petereit et al., “Formulation and process consideration affecting the stability of solid dosage forms formulated with methacrylate copolymers”,European Journal of Pharmaceutics and Biopharmaceutics., 47 (1995) 15-25.
M. Wessling et al., “Tackiness of acrylic and cellulosic polymer films used in the coating of solid dosage forms”,European Journal of Pharmaceutics and Biopharmaceutics., 47 (1999) 7378.
A.Y. Lin et al., “Study of crystallization of endogenous surfactant in Eudragit NE30D-free films and its influence on drug release properties of controlled-release diphenhydramine HCI pellets coated with Eudragit NE #)D”,AAPS Pharmsci 2001; 3(2) article 14.

Affiliated with

Also associated with

Rating

Film coating does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Film coating, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Film coating will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4220723